Biologics
Scope
Date
~
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to break ground on 1st local CDMO plant in 2024
South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $242 mn order from Bristol Myers Squibb
Samsung Biologics Co., the world’s largest contract drugmaker, said on Monday it has signed an agreement to produce $242 million worth of anti...
Sep 18, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
Bio & Pharma
Novomics expands presence in Chinese cancer market
South Korean molecular diagnostics company Novomics Co. announced on Wednesday that it has signed a collaboration agreement with Chinese molecular d...
Jul 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Novartis $391 mn deal powers Samsung Biologics backlogs to record high
Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...
Jul 10, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $897 mn in two deals with Pfizer
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO) in terms of production capacity, said on Tuesday it has w...
Jul 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO
Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double production by 2032; eyes ADCs, M&As
BOSTON – Samsung Biologics Co., the world’s No. 1 contract drugmaker, plans to more than double its total annual production capacity to ...
Jun 07, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Bertis releases two academic findings at AOHUPO conference
Bertis, South Korean company specializing in the development of proteomics-based precision medicine technology, announced on Monday that it presente...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung to nurture biotech as next growth engine after chips: Lee
Samsung Group leader Lee Jae-yong, currently in the US, has vowed to make biotechnology the conglomerate’s second core strategic business afte...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics invests in S.Korean bio-venture Pinotbio
South Korea’s Lotte Biologics Co. said on Friday that it has made an equity investment in Pinotbio, Inc. for the development of antibody-drug ...
Apr 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to invest additional $48 mn in US plant
South Korea’s Lotte Biologics Co. held a plaque ceremony on Monday to commemorate the acquisition of a pharmaceutical production plant from Br...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, Excellgene to collaborate on CDO biz
Lotte Biologics, South Korea's biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Sunday that it has...
Apr 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to invest $1.5 bn for 5th CDMO factory
Samsung Biologics Co. is slated to inject 2 trillion won ($1.5 billion) to build its fifth plant in South Korea. It will be a fast follow-up investm...
Mar 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Prestige Biologics attracts $59 mn overseas investment
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, announced on Tuesday th...
Mar 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics bags $183 million CMO order from Pfizer
Samsung Biologics Co., the world’s No. 1 contract drug maker in terms of production capacity, has won a $182.7 million contract manufacturing ...
Mar 02, 2023 (Gmt+09:00)
-
Earnings
Samsung Biologics’ profit near doubles on strong orders
Samsung Biologics Co., the world’s top contract drugmaker, said its profit almost doubled last year thanks to more orders as its sales surged ...
Jan 29, 2023 (Gmt+09:00)
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics receives Terra Carta Seal
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it was awarded the Sustainable Markets Initiative’s Ter...
Jan 11, 2023 (Gmt+09:00)